The use of radiomics and artificial intelligence for sickle cell disease

Raffaella Colombatti, MD, PhD, University of Padova, Padova, Italy, shares some insights into the use of radiomics and artificial intelligence for sickle cell disease (SCD) and the GENOMED4ALL European project. This interview took place at the European Hematology Association (EHA) Congress 2022 held in Vienna, Austria.